#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Palmoplantar pustulosis Amyloidosis White matter lesion Hereditary angioedema with C1 esterase inhibitor deficiency Arteriosclerosis Short stature homeobox gene mutation Diffuse large B-cell lymphoma Giant cell tumour of tendon sheath Prostate cancer Undifferentiated sarcoma Oesophageal achalasia B-cell lymphoma Encephalitis autoimmune Metachromatic leukodystrophy Penile cancer More trials…

    Learn about Rare Diseases

    Pemphigus – Trials in Disease Short-bowel syndrome – Treatment Burkitt’s lymphoma – Life with Disease Toxic epidermal necrolysis – Diagnostics Marginal zone lymphoma – Trials in Disease X-linked lymphoproliferative syndrome Mantle cell lymphoma refractory – Treatment Undifferentiated sarcoma – Basic Information Alternating hemiplegia of childhood – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efavirenz IDROXIOLEIC ACID Zoledronic Acid Ponsegromab HUMAN COAGULATION FACTOR XIII Etifoxine Hydrochloride Bms-986435 Nimotuzumab Methadone Hydrochloride Somatropin Icosapent Ethyl Vx-522 Mesna Apraglutide Vusolimogene Oderparepvec Mycophenolic Acid Follitropin Alfa Ciclesonide Lixudebart Flortaucipir (18F) More therapies…

    Learn about Your Condition

    Leber's congenital amaurosis Burning mouth syndrome Anal cancer metastatic Abdominal infection Post-acute COVID-19 syndrome Polycythaemia vera Rhabdomyosarcoma recurrent Peritoneal neoplasm Squamous cell carcinoma Tetanus Rectosigmoid cancer Encephalitis autoimmune Carcinoid tumour pulmonary Leukaemia Lymphangioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praxis Reinfeld Mitte

Praxis Reinfeld Mitte

Paul-von-Schoenaich-Straße 29, Reinfeld, 23858, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • 2,4 DICHLOROBENZYL ALCOHOL
    • BENZYDAMINE HYDROCHLORIDE
    Germany

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium Estonia Finland France Germany Italy +1

  • Study of baxdrostat compared to placebo to treat adults with primary aldosteronism

    Not recruiting

    3 1
    Investigated Diseases:
    • Primary hyperaldosteronism
    Investigated Drugs:
    • Baxdrostat
    France Germany Italy Spain

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!